Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
PML risk stratification using anti-JCV antibody index and L-selectin.
Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes.
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial.
Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.
Ethical challenges in paediatric clinical trials in multiple sclerosis.
Familial comorbidity of bipolar disorder and multiple sclerosis: Genetic susceptibility, coexistence or causal relationship?
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis.
Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
Commentary on "Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection"
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Development and initial validation of the Perceptions of Parental Illness Questionnaire (PPIQ).
MicroRNAs Regulate Human Brain Endothelial Cell-Barrier Function in Inflammation: Implications for Multiple Sclerosis.
Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS.
Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions.
Changes of synapses in experimental autoimmune encephalomyelitis by using Fasudil.
Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis.
Gateway to wellness: an occupational therapy collaboration with the national multiple sclerosis society.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.
Pages
« first
‹ previous
…
214
215
216
217
218
219
220
221
222
…
next ›
last »